TAO Synergies raises $11M in private placement; terminates Alkon agreement; appoints Vice-Chairman

TAO Synergies Inc.

Sold 11,000 Series E convertible preferred shares ($1,000 stated value) and warrants for 1.375M common shares at $8.00; $11M gross proceeds.
Investors include existing stockholders, James Altucher, and new strategic investor DCG; expected close Oct 15.
Proceeds for general corporate purposes and working capital, focusing on Bittensor (TAO) ecosystem investments.
Terminated consulting agreement with Dr. Daniel Alkon effective Oct 3; remains liable for incentive fees on Bryostatin transactions for one year.
Appointed Bruce Bernstein as Vice-Chairman of the Board effective Oct 1; William Singer remains independent director.

item 1.01item 3.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.